Your browser doesn't support javascript.
loading
Peptide-based PET quantifies target engagement of PD-L1 therapeutics.
Kumar, Dhiraj; Lisok, Ala; Dahmane, Elyes; McCoy, Matthew; Shelake, Sagar; Chatterjee, Samit; Allaj, Viola; Sysa-Shah, Polina; Wharram, Bryan; Lesniak, Wojciech G; Tully, Ellen; Gabrielson, Edward; Jaffee, Elizabeth M; Poirier, John T; Rudin, Charles M; Gobburu, Jogarao Vs; Pomper, Martin G; Nimmagadda, Sridhar.
Afiliação
  • Kumar D; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Lisok A; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Dahmane E; Center for Translational Medicine, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
  • McCoy M; Innovation Center for Biomedical Informatics, Georgetown University, Washington, DC, USA.
  • Shelake S; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Chatterjee S; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Allaj V; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Sysa-Shah P; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Wharram B; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Lesniak WG; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Tully E; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Gabrielson E; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Jaffee EM; The Sidney Kimmel Comprehensive Cancer Center and the Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Poirier JT; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Rudin CM; The Sidney Kimmel Comprehensive Cancer Center and the Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Gobburu JV; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Pomper MG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Nimmagadda S; Center for Translational Medicine, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
J Clin Invest ; 129(2): 616-630, 2019 02 01.
Article em En | MEDLINE | ID: mdl-30457978

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Compostos Radiofarmacêuticos / Tomografia por Emissão de Pósitrons / Antígeno B7-H1 / Antineoplásicos Imunológicos / Modelos Biológicos / Proteínas de Neoplasias / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: J Clin Invest Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Compostos Radiofarmacêuticos / Tomografia por Emissão de Pósitrons / Antígeno B7-H1 / Antineoplásicos Imunológicos / Modelos Biológicos / Proteínas de Neoplasias / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: J Clin Invest Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos